Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
<p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in t...
Sábháilte in:
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | LEABHAR |
| Foilsithe / Cruthaithe: |
Archives of Hepatitis Research - Peertechz Publications,
2017-05-29.
|
| Ábhair: | |
| Rochtain ar líne: | Connect to this object online. |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ahr_000013 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Meng-Lan Wang |e author |
| 700 | 1 | 0 | |a Dong-Mei Zhang |e author |
| 700 | 1 | 0 | |a En-Qiang Chen |e author |
| 245 | 0 | 0 | |a Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports |
| 260 | |b Archives of Hepatitis Research - Peertechz Publications, |c 2017-05-29. | ||
| 520 | |a <p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.</p> | ||
| 540 | |a Copyright © Meng-Lan Wang et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Case Report |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ahr.000013 |z Connect to this object online. |